SI1250328T1 - Aminski derivati dihidro-1,3,5-triazina in njihova terapevtska uporaba - Google Patents

Aminski derivati dihidro-1,3,5-triazina in njihova terapevtska uporaba

Info

Publication number: SI1250328T1
Authority: SI; Slovenia
Prior art keywords: dihydro; therapeutic uses; amine derivatives; triazine amine; triazine
Prior art date: 2000-01-26

Application number

SI200130600T

Other languages

English (en)

Other versions

SI1250328T2 (sl

Inventor

Gurard Moinet

Daniel Cravo

Liliane Doare

Micheline Kergoat

Didier Mesangeau

Original Assignee

Merck Sante Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-26

Filing date

2001-01-25

Publication date

2006-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8846333&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1250328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-25 Application filed by Merck Sante Sas filed Critical Merck Sante Sas

2006-10-31 Publication of SI1250328T1 publication Critical patent/SI1250328T1/sl

2010-09-30 Publication of SI1250328T2 publication Critical patent/SI1250328T2/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/72—Heterocyclic compounds containing 1,3,5-triazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SI200130600T 2000-01-26 2001-01-25 Aminski derivati dihidro triazina in njihova terapevtska uporaba SI1250328T2 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0000996A FR2804113B1 (fr)	2000-01-26	2000-01-26	Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
PCT/FR2001/000241 WO2001055122A1 (fr)	2000-01-26	2001-01-25	Derives amines de dihydro-1,3,5-triazine et leurs applications en therapeutique
EP01907700A EP1250328B2 (fr)	2000-01-26	2001-01-25	Derives amines de dihydro-1,3,5-triazine et leurs applications en therapeutique

Publications (2)

Publication Number	Publication Date
SI1250328T1 true SI1250328T1 (sl)	2006-10-31
SI1250328T2 SI1250328T2 (sl)	2010-09-30

Family

ID=8846333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200130600T SI1250328T2 (sl)	2000-01-26	2001-01-25	Aminski derivati dihidro triazina in njihova terapevtska uporaba

Country Status (37)

Country	Link
US (4)	US7034021B2 (sl)
EP (1)	EP1250328B2 (sl)
JP (1)	JP4926357B2 (sl)
KR (1)	KR100722438B1 (sl)
CN (1)	CN1195743C (sl)
AP (1)	AP2002002578A0 (sl)
AR (1)	AR027293A1 (sl)
AT (1)	ATE332294T1 (sl)
AU (1)	AU782307B2 (sl)
BG (1)	BG106933A (sl)
BR (1)	BRPI0107815B8 (sl)
CA (1)	CA2397636C (sl)
CY (1)	CY1105344T1 (sl)
CZ (1)	CZ303445B6 (sl)
DE (1)	DE60121294T3 (sl)
DK (1)	DK1250328T4 (sl)
EA (1)	EA005378B1 (sl)
EE (1)	EE05003B1 (sl)
ES (1)	ES2267715T5 (sl)
FR (1)	FR2804113B1 (sl)
HK (1)	HK1050529A1 (sl)
HR (1)	HRP20020625A2 (sl)
HU (1)	HU230790B1 (sl)
IL (1)	IL150530A0 (sl)
IS (1)	IS6467A (sl)
MA (1)	MA25650A1 (sl)
MX (1)	MXPA02007232A (sl)
NO (1)	NO20023532L (sl)
OA (1)	OA12165A (sl)
PL (1)	PL205345B1 (sl)
PT (1)	PT1250328E (sl)
SI (1)	SI1250328T2 (sl)
SK (1)	SK287647B6 (sl)
TN (1)	TNSN01012A1 (sl)
WO (1)	WO2001055122A1 (sl)
YU (1)	YU55602A (sl)
ZA (1)	ZA200205314B (sl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2804113B1 (fr) *	2000-01-26	2004-06-18	Lipha	Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
KR101027366B1 (ko) *	2002-12-17	2011-04-11	하마리야꾸힝고오교가부시끼가이샤	신규한 2,4-디아미노-1,3,5-트리아진 유도체
FR2853650B1 (fr) *	2003-04-10	2006-07-07	Merck Sante Sas	Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
JP4859922B2 (ja) *	2005-06-14	2012-01-25	シェーリングコーポレイション	アスパルチルプロテアーゼ阻害剤としての化合物の調製および使用
FR2896159B1 (fr) *	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
FR2896160B1 (fr) *	2006-01-13	2008-04-25	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agonistes du ppar alpha.
FR2896157B1 (fr) *	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
FR2896161B1 (fr) *	2006-01-13	2008-04-04	Merck Sante Soc Par Actions Si	Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique.
FR2896158B1 (fr) *	2006-01-13	2008-09-12	Merck Sante Soc Par Actions Si	Combinaison de derives de triazine et d'inhibiteurs de la hmg-coa reductase.
DE102007054416A1 (de)	2007-11-13	2009-05-14	Studiengesellschaft Kohle Mbh	Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind
DE102008007314A1 (de) *	2008-02-02	2009-08-06	Merck Patent Gmbh	Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
US8309325B2 (en) *	2008-05-20	2012-11-13	Merck Sharp & Dohme Corp.	Efficient production of heterologous proteins using mannosyl transferase inhibitors
PL2300444T3 (pl) *	2008-05-23	2016-08-31	Poxel Sas	Sposób syntezy pochodnych 3,6-dihydro-1,3,5-triazyny
US20110207926A1 (en) *	2008-08-25	2011-08-25	Hamari Chemicals, Ltd.	Novel dihydrotriazine derivative
CN102245581A (zh) *	2008-12-12	2011-11-16	普克塞尔公司	用于治疗与ampk活性有关的疾病的四氢三嗪化合物
CA2746479C (en) *	2008-12-12	2016-11-08	Merck Patent Gmbh	Combination of insulin with triazine derivatives and its use for treating diabetes
WO2010103040A1 (en)	2009-03-10	2010-09-16	INSERM (Institut National de la Santé et de la Recherche Médicale)	5'-adenosine monophosphate-activated protein kinase (ampk) activators for treating pulmonary hypertension
WO2010109015A1 (en)	2009-03-26	2010-09-30	Poxel	Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization
FR2948028B1 (fr)	2009-07-17	2011-12-02	Merck Sante Sas	Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine
FR2948027A1 (fr) *	2009-07-17	2011-01-21	Merck Sante Sas	Derives amines de dihydro-1,3,5-triazine pour leur utilisation dans le traitement des maladies associees a une ischemie et/ou une reperfusion
FR2948026B1 (fr)	2009-07-17	2011-12-02	Merck Sante Sas	Derives amines de dihydro-1,3,5-triazine
TWI436768B (zh) *	2010-06-09	2014-05-11	Poxel	第２型糖尿病之治療
EP2579879B1 (en) *	2010-06-09	2016-03-23	Poxel	Triazine derivatives for delaying the onset of type 1 diabetes
JP5758010B2 (ja)	2010-12-01	2015-08-05	ポクセルＰｏｘｅｌ	酒石酸によるトリアジン誘導体エナンチオマーの分離
RU2658819C2 (ru) *	2016-05-26	2018-06-25	федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный технический университет"	Применение гетероциклических гидразонов в качестве средств, обладающих антигликирующей активностью
FR3068601B1 (fr) *	2017-07-05	2021-02-19	Eric Joseph Marie Fulgence Janin	Utilisation de l'imeglimine pour la prevention et/ou le traitement du carcinome hepatocellulaire
JP2020536121A (ja)	2017-10-02	2020-12-10	ポクセルＰｏｘｅｌ	駆出率が保持された心不全を治療する方法
MX2020013210A (es)	2018-06-06	2021-02-26	Metavant Sciences Gmbh	Metodos de tratamiento de sujetos que padecen diabetes con enfermedad renal cronica.
SG11202010322XA (en)	2018-06-14	2020-11-27	Poxel	Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
WO2022152138A1 (zh) *	2021-01-15	2022-07-21	中国医药研究开发中心有限公司	稠和杂环类化合物及其制备方法和医药用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3287366A (en) *	1963-12-24	1966-11-22	American Cyanamid Co	Novel 1, 2-dihydro-s-triazines
US3286366A (en) *	1964-10-26	1966-11-22	Seligman Monroe	Apparatus for freeze drying products in small containers
JPS4856692A (sl) *	1971-11-19	1973-08-09
JPS4864088A (sl) *	1971-12-13	1973-09-05
JPS5414986A (en) *	1977-07-01	1979-02-03	Taiho Pharmaceutical Co Ltd	Production of dihydrooss triazine derivative
US4246408A (en) *	1979-03-08	1981-01-20	Icn Pharmaceuticals	Imidazo[1,2-a]-s-triazine
GR74944B (sl) *	1980-07-02	1984-07-12	Merck & Co Inc
US4277602A (en) *	1980-07-02	1981-07-07	Merck & Co., Inc.	3-Amino-5-substituted-6-halo-N-(3,4-dihydro-6-substituted-1,3,5-truazin-2-yl)2-pyrazinecarboxamides
US4576945A (en) *	1982-10-26	1986-03-18	Sanders Mark E	Hexaalkylmelamine-amino-oxy compounds
JPS6141915A (ja)	1984-08-03	1986-02-28	Omron Tateisi Electronics Co	測距装置
DD257010A1 (de) *	1987-01-13	1988-06-01	Berlin Chemie Veb	Ergotrope mittel
DE3801113A1 (de) *	1987-07-23	1989-02-02	Bayer Ag	Substituierte triazine
IT1244870B (it) *	1990-09-11	1994-09-12	Ministero Dall Uni E Della Ric	Composti ammelinici
DE19641692A1 (de) *	1996-10-10	1998-04-23	Bayer Ag	Substituierte 2,4-Diamino-1,3,5-triazine
AU1818599A (en) *	1997-12-12	1999-07-05	Abbott Laboratories	Triazine angiogenesis inhibitors
FR2804113B1 (fr) *	2000-01-26	2004-06-18	Lipha	Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique

2000
- 2000-01-26 FR FR0000996A patent/FR2804113B1/fr not_active Expired - Lifetime
2001
- 2001-01-24 TN TNTNSN01012A patent/TNSN01012A1/fr unknown
- 2001-01-25 EP EP01907700A patent/EP1250328B2/fr not_active Expired - Lifetime
- 2001-01-25 SI SI200130600T patent/SI1250328T2/sl unknown
- 2001-01-25 CA CA2397636A patent/CA2397636C/fr not_active Expired - Lifetime
- 2001-01-25 WO PCT/FR2001/000241 patent/WO2001055122A1/fr active IP Right Grant
- 2001-01-25 AP APAP/P/2002/002578A patent/AP2002002578A0/en unknown
- 2001-01-25 MX MXPA02007232A patent/MXPA02007232A/es active IP Right Grant
- 2001-01-25 DK DK01907700.7T patent/DK1250328T4/da active
- 2001-01-25 SK SK976-2002A patent/SK287647B6/sk not_active IP Right Cessation
- 2001-01-25 JP JP2001555064A patent/JP4926357B2/ja not_active Expired - Lifetime
- 2001-01-25 CN CNB018041027A patent/CN1195743C/zh not_active Expired - Lifetime
- 2001-01-25 HU HU0204087A patent/HU230790B1/hu unknown
- 2001-01-25 CZ CZ20022462A patent/CZ303445B6/cs not_active IP Right Cessation
- 2001-01-25 DE DE60121294T patent/DE60121294T3/de not_active Expired - Lifetime
- 2001-01-25 PL PL357191A patent/PL205345B1/pl unknown
- 2001-01-25 IL IL15053001A patent/IL150530A0/xx unknown
- 2001-01-25 KR KR1020027009459A patent/KR100722438B1/ko active IP Right Grant
- 2001-01-25 EE EEP200200414A patent/EE05003B1/xx unknown
- 2001-01-25 OA OA1200200225A patent/OA12165A/fr unknown
- 2001-01-25 PT PT01907700T patent/PT1250328E/pt unknown
- 2001-01-25 US US10/181,223 patent/US7034021B2/en not_active Expired - Lifetime
- 2001-01-25 BR BR0107815A patent/BRPI0107815B8/pt not_active IP Right Cessation
- 2001-01-25 EA EA200200790A patent/EA005378B1/ru not_active IP Right Cessation
- 2001-01-25 AT AT01907700T patent/ATE332294T1/de active
- 2001-01-25 ES ES01907700T patent/ES2267715T5/es not_active Expired - Lifetime
- 2001-01-25 YU YU55602A patent/YU55602A/sh unknown
- 2001-01-25 AU AU35603/01A patent/AU782307B2/en not_active Expired
- 2001-01-26 AR ARP010100337A patent/AR027293A1/es active IP Right Grant
2002
- 2002-07-03 ZA ZA2002/05314A patent/ZA200205314B/en unknown
- 2002-07-11 IS IS6467A patent/IS6467A/is unknown
- 2002-07-17 BG BG106933A patent/BG106933A/xx unknown
- 2002-07-22 MA MA26737A patent/MA25650A1/fr unknown
- 2002-07-24 HR HR20020625A patent/HRP20020625A2/hr not_active Application Discontinuation
- 2002-07-24 NO NO20023532A patent/NO20023532L/no not_active Application Discontinuation
2003
- 2003-04-11 HK HK03102653A patent/HK1050529A1/xx not_active IP Right Cessation
2005
- 2005-03-22 US US11/085,145 patent/US7452883B2/en not_active Expired - Lifetime
2006
- 2006-09-08 CY CY20061101287T patent/CY1105344T1/el unknown
2007
- 2007-10-30 US US11/976,936 patent/US7767676B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/979,140 patent/US20080108591A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2397636A1 (fr)	2001-08-02
TNSN01012A1 (fr)	2005-11-10
EP1250328A1 (fr)	2002-10-23
PL357191A1 (en)	2004-07-26
CN1195743C (zh)	2005-04-06
ES2267715T5 (es)	2010-06-10
BRPI0107815B8 (pt)	2021-05-25
SK287647B6 (sk)	2011-05-06
US20080108619A1 (en)	2008-05-08
US7034021B2 (en)	2006-04-25
HK1050529A1 (en)	2003-06-27
JP4926357B2 (ja)	2012-05-09
CA2397636C (fr)	2010-04-06
KR100722438B1 (ko)	2007-05-29
ZA200205314B (en)	2005-07-27
SI1250328T2 (sl)	2010-09-30
EE05003B1 (et)	2008-04-15
DE60121294T3 (de)	2010-09-23
HUP0204087A2 (hu)	2003-04-28
DE60121294D1 (de)	2006-08-17
BG106933A (en)	2003-07-31
AU782307B2 (en)	2005-07-21
AU3560301A (en)	2001-08-07
AR027293A1 (es)	2003-03-19
MXPA02007232A (es)	2003-10-15
BR0107815A (pt)	2002-10-29
KR20020075395A (ko)	2002-10-04
DK1250328T3 (da)	2006-10-30
DK1250328T4 (da)	2010-06-28
WO2001055122A1 (fr)	2001-08-02
DE60121294T2 (de)	2007-08-30
EP1250328B1 (fr)	2006-07-05
YU55602A (sh)	2005-03-15
HRP20020625A2 (en)	2003-10-31
ES2267715T3 (es)	2007-03-16
CY1105344T1 (el)	2010-03-03
EA200200790A1 (ru)	2003-02-27
PL205345B1 (pl)	2010-04-30
OA12165A (fr)	2006-05-08
BRPI0107815B1 (pt)	2017-08-29
EE200200414A (et)	2003-10-15
NO20023532D0 (no)	2002-07-24
MA25650A1 (fr)	2002-12-31
CZ20022462A3 (cs)	2003-04-16
NO20023532L (no)	2002-09-25
IS6467A (is)	2002-07-11
FR2804113A1 (fr)	2001-07-27
IL150530A0 (en)	2003-02-12
ATE332294T1 (de)	2006-07-15
EP1250328B2 (fr)	2010-04-21
US20030109530A1 (en)	2003-06-12
PT1250328E (pt)	2006-10-31
US7452883B2 (en)	2008-11-18
EA005378B1 (ru)	2005-02-24
US20050165022A1 (en)	2005-07-28
AP2002002578A0 (en)	2002-09-30
US20080108591A1 (en)	2008-05-08
SK9762002A3 (en)	2003-05-02
US7767676B2 (en)	2010-08-03
CN1404472A (zh)	2003-03-19
JP2003520858A (ja)	2003-07-08
HUP0204087A3 (en)	2006-01-30
CZ303445B6 (cs)	2012-09-19
HU230790B1 (en)	2018-05-02
FR2804113B1 (fr)	2004-06-18

Publication	Publication Date	Title
IL150530A0 (en)	2003-02-12	Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
HUP0402113A3 (en)	2012-05-29	4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
HK1048999A1 (zh)	2003-04-25	氮雜䓬吲衍生物，它們的製備和應用
HK1048636A1 (en)	2003-04-11	N-(indolcarbonyl-)piperazin derivatives
HK1081954A1 (en)	2006-05-26	Novel 1,4-diazabicycloalkane derivatives, their preparation and use
AU2002359126A8 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
AU2002359123A8 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
PL350853A1 (en)	2003-02-10	1-aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
IL154675A0 (en)	2003-09-17	N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
HUP0600238A3 (en)	2009-12-28	Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HUP0102832A3 (en)	2002-03-28	Herbicidal substituted 2,4-diamino-1,3,5-triazine derivatives, preparation and use thereof
HUP0202377A3 (en)	2002-12-28	N-substituted perhydrodiazines, preparation and use thereof
PL365342A1 (en)	2004-12-27	Mikanolide derivatives, their preparation and therapeutic uses
HUP0103358A3 (en)	2002-10-28	N-substituted azabicycloheptane derivatives, production and use thereof
AU7815201A (en)	2002-02-18	Synthetic salicylihalamides, apicularens and derivatives thereof
AU7422100A (en)	2001-04-23	Alkyl-amino-1,3,5-triazines and their use as herbicides
HRP20020971A2 (en)	2005-02-28	4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
GB2350361B (en)	2003-12-03	3,4,5-tricyanophenyl derivatives
HUP0103099A3 (en)	2002-12-28	N-substituted azabicycloheptane derivatives, production and use thereof
SI1105388T1 (sl)	2003-10-31	N-substituirani azabicikloheptanski derivati, njihova proizvodnja in uporaba
SI1104419T1 (sl)	2002-10-31	N-substituirani azabicikloheptanski derivati, njihova priprava in uporaba
ZA200002368B (en)	2001-01-16	Synthesis of 5,5'-Diformyl-2,2'Difuran and Derivatives thereof.
ZA200204266B (en)	2003-08-28	Arylamine derivatives and their use as anti-telomerase agent.
PL353421A1 (en)	2003-10-20	New derivatives of symmetrical 1,3,5-triazine
SI1198453T1 (sl)	2003-10-31	Derivati n-(indolkarbonil)-piperazina kot ligandi 5-ht2a-receptorja